Location
Denmark, Europe
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
Health & Hospital Services
Pharmaceuticals
About Investor
Henrijette Richter serves as Managing Partner at Sofinnova Partners. Her investment focus includes Pharmaceuticals and Health & Hospital Services, with typical stages of Seed and Series A, and an investment range of $100K - $5.0M. She joined Sofinnova in 2014 after roles at Novo Seeds and Sunstone Capital. She holds a PhD in Molecular Biology from the University of Copenhagen and completed a postdoctoral fellowship at MIT Center for Cancer Research.
Previous investments
Asceneuron
100M |2024
31M |2015
Freya Biosciences
38M |2023
Nitrase Therapeutics
7M |2021
38M |2020
Similar Investors
JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,WT
William Tunstall-Pedoe
United Kingdom, Europe
$10K - $500K
Pre Seed
,Seed
,CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,EV
Eze Vidra
United Kingdom, Europe
$300K - $1.5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP